NO20022729D0 - Nye (aminopropyl-)metylfosfinsyrer - Google Patents

Nye (aminopropyl-)metylfosfinsyrer

Info

Publication number
NO20022729D0
NO20022729D0 NO20022729A NO20022729A NO20022729D0 NO 20022729 D0 NO20022729 D0 NO 20022729D0 NO 20022729 A NO20022729 A NO 20022729A NO 20022729 A NO20022729 A NO 20022729A NO 20022729 D0 NO20022729 D0 NO 20022729D0
Authority
NO
Norway
Prior art keywords
aminopropyl
new
methylphosphinic
acids
methylphosphinic acids
Prior art date
Application number
NO20022729A
Other languages
English (en)
Other versions
NO20022729L (no
Inventor
Kosrat Amin
Thomas Elebring
Peter Guzzo
Thomas Olsson
Marianne Swansson
Sverker Von Unge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022729D0 publication Critical patent/NO20022729D0/no
Publication of NO20022729L publication Critical patent/NO20022729L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/30Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20022729A 1999-12-09 2002-06-07 Nye (aminopropyl-)metylfosfinsyrer NO20022729L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904507A SE9904507D0 (sv) 1999-12-09 1999-12-09 New compounds
PCT/SE2000/002427 WO2001041743A1 (en) 1999-12-09 2000-12-04 New (aminopropyl)methylphosphinic acids

Publications (2)

Publication Number Publication Date
NO20022729D0 true NO20022729D0 (no) 2002-06-07
NO20022729L NO20022729L (no) 2002-07-09

Family

ID=20418062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022729A NO20022729L (no) 1999-12-09 2002-06-07 Nye (aminopropyl-)metylfosfinsyrer

Country Status (27)

Country Link
US (1) US6596711B1 (no)
EP (1) EP1239843A1 (no)
JP (1) JP2003516346A (no)
KR (1) KR100752010B1 (no)
CN (1) CN1200713C (no)
AR (1) AR033350A1 (no)
AU (1) AU780259B2 (no)
BR (1) BR0016291A (no)
CA (1) CA2393510A1 (no)
CO (1) CO5261538A1 (no)
CZ (1) CZ20021984A3 (no)
EE (1) EE200200287A (no)
HK (1) HK1053066A1 (no)
HU (1) HUP0300386A3 (no)
IL (2) IL150090A0 (no)
IS (1) IS6409A (no)
MX (1) MXPA02005537A (no)
NO (1) NO20022729L (no)
NZ (1) NZ519377A (no)
PL (1) PL357115A1 (no)
RU (1) RU2267495C2 (no)
SE (1) SE9904507D0 (no)
SK (1) SK7632002A3 (no)
TW (1) TWI225415B (no)
UA (1) UA73149C2 (no)
WO (1) WO2001041743A1 (no)
ZA (1) ZA200204122B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
TW200407110A (en) 2001-11-23 2004-05-16 Astrazeneca Ab New use for the treatment of gastroesophageal reflux disease
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
DE10305463A1 (de) * 2003-02-04 2004-08-12 Schering Ag Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
SE0402462D0 (sv) * 2004-10-08 2004-10-08 Astrazeneca Ab New process
US7745474B2 (en) 2005-12-23 2010-06-29 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
WO2007073300A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Gaba-b receptor modulators
JP5520816B2 (ja) * 2007-05-04 2014-06-11 アストラゼネカ・アクチエボラーグ アミンおよびアミンオキシドで開始するアルキルホスフィン酸の合成方法
JP2010534239A (ja) * 2007-07-25 2010-11-04 アストラゼネカ・アクチエボラーグ Nerdの治療のための(3−アミノ−2−フルオロプロピル)ホスフィン酸の使用
PE20091311A1 (es) * 2007-12-21 2009-09-30 Astrazeneca Ab Nuevo proceso para preparar la forma a del acido (2r)-(3-amino-2-fluoropropil)fosfinico
US20110034420A1 (en) * 2007-12-21 2011-02-10 Ida Hoyer Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
JP2011026260A (ja) * 2009-07-28 2011-02-10 Central Glass Co Ltd 3位に脱離基を有する2−フルオロプロピルアミン保護体または該アミンn−アルキル保護体
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449046A (de) 1963-07-09 1967-12-31 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
GB8425872D0 (en) 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
EP0250572A1 (en) 1986-01-03 1988-01-07 The University Of Melbourne Gastro-oesophageal reflux composition
GB8820266D0 (en) 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
FR2663934B1 (fr) 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
FR2722192A1 (fr) 1994-07-06 1996-01-12 Adir Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9420784D0 (en) 1994-10-14 1994-11-30 Glaxo Group Ltd Medicaments
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
TWI225415B (en) 2004-12-21
HUP0300386A2 (hu) 2003-07-28
HK1053066A1 (en) 2003-10-10
CA2393510A1 (en) 2001-06-14
EE200200287A (et) 2003-08-15
WO2001041743A1 (en) 2001-06-14
NZ519377A (en) 2003-11-28
JP2003516346A (ja) 2003-05-13
CO5261538A1 (es) 2003-03-31
IL150090A0 (en) 2002-12-01
KR100752010B1 (ko) 2007-08-28
NO20022729L (no) 2002-07-09
SE9904507D0 (sv) 1999-12-09
HUP0300386A3 (en) 2005-08-29
SK7632002A3 (en) 2003-03-04
CN1413104A (zh) 2003-04-23
IL150090A (en) 2006-08-01
AR033350A1 (es) 2003-12-17
MXPA02005537A (es) 2004-09-10
CZ20021984A3 (cs) 2002-11-13
UA73149C2 (en) 2005-06-15
RU2002113916A (ru) 2004-01-10
AU2241201A (en) 2001-06-18
ZA200204122B (en) 2003-10-29
EP1239843A1 (en) 2002-09-18
RU2267495C2 (ru) 2006-01-10
IS6409A (is) 2002-06-06
KR20020060993A (ko) 2002-07-19
PL357115A1 (en) 2004-07-12
AU780259B2 (en) 2005-03-10
US6596711B1 (en) 2003-07-22
CN1200713C (zh) 2005-05-11
BR0016291A (pt) 2002-08-13

Similar Documents

Publication Publication Date Title
DK1240172T3 (da) Nye aminopropylphosphinsyrer
NO20014518L (no) Nye forbindelser
DK1202994T3 (da) Nye forbindelser
NO20021436L (no) Nye forbindelser
NO20026064L (no) Nye forbindelser
NO20023933L (no) Nye forbindelser
NO20020810D0 (no) Nye fenylpiperaziner
NO20015383D0 (no) Nye forbindelser
NO20022729L (no) Nye (aminopropyl-)metylfosfinsyrer
NO20025151D0 (no) Nye forbindelser
NO20031141D0 (no) Nye forbindelser
EE200100708A (et) Asendatud fenoksüäädikhapped
NO20010860D0 (no) Nye forbindelser
NO20026162L (no) Nye forbindelser
DE50108104D1 (de) Beta-thio-aminosäuren
NO20026081D0 (no) Nye forbindelser
NO20030274D0 (no) Nye aryleten-sulfonamider
NO995945D0 (no) Nye forbindelser
NO20015374L (no) Nye forbindelser
NO20013601D0 (no) Nye morfolinobenzamidsalter
NO20014629D0 (no) Nye forbindelser
NO20016273D0 (no) Nye forbindelser
NO20010584L (no) Nye forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application